Literature DB >> 32492526

Inflammatory predictors of neurobehavior in very preterm infants.

Marliese Dion Nist1, Rita H Pickler2, Tondi M Harrison3, Deborah K Steward4, Abigail B Shoben5.   

Abstract

BACKGROUND: Preterm infants are at risk for impaired neurodevelopment. Inflammation may be an important modifiable mediator of preterm birth and neurodevelopmental impairment, but few studies have examined longitudinal measures of inflammation.
OBJECTIVE: To determine the relationship between longitudinal measures of inflammation and neurobehavior in very preterm infants. STUDY
DESIGN: Non-experimental, repeated measures cohort study.
METHODS: Very preterm infants were enrolled between October 2017 and December 2018. Blood was collected weekly until 35 weeks post-menstrual age for the quantification of plasma cytokines. Neurobehavior was assessed at 35 weeks post-menstrual age using the cluster scores for motor development and vigor and alertness/orientation from the Neurobehavioral Assessment of the Preterm Infant. Multiple linear regression models with robust standard errors were used to analyze the data. Average levels of individual cytokines, cytokine trends, and composite scores were used as measures of inflammation.
RESULTS: Seventy-three infants were enrolled in the study. Interleukin-1 receptor antagonist was associated with motor development and vigor scores. Interleukin-6 was associated with alertness/orientation scores. Tumor necrosis factor-alpha and composite scores of inflammation were associated with motor development and vigor and alertness/orientation scores. There were interactions with post-menstrual age at birth and infant sex.
CONCLUSION: Inflammation may be an important predictor of short-term neurobehavior in preterm infants. Interleukin-1 receptor antagonist, interleukin-6, and tumor necrosis factor-alpha are key cytokines for studies of preterm infants, but composite scores may be a better measure of inflammation than individual cytokines. Inflammation can be damaging to the immature brain and may be a specific target for future interventions to improve outcomes.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cytokine; Inflammation; Neurobehavior; Neurodevelopment; Preterm infant

Year:  2020        PMID: 32492526      PMCID: PMC7363528          DOI: 10.1016/j.earlhumdev.2020.105078

Source DB:  PubMed          Journal:  Early Hum Dev        ISSN: 0378-3782            Impact factor:   2.079


  59 in total

1.  Multiplex assays of inflammatory markers, a description of methods and discussion of precautions - Our experience through the last ten years.

Authors:  Kristin Skogstrand
Journal:  Methods       Date:  2011-10-07       Impact factor: 3.608

2.  Systemic Inflammation during the First Postnatal Month and the Risk of Attention Deficit Hyperactivity Disorder Characteristics among 10 year-old Children Born Extremely Preterm.

Authors:  Elizabeth N Allred; Olaf Dammann; Raina N Fichorova; Stephen R Hooper; Scott J Hunter; Robert M Joseph; Karl Kuban; Alan Leviton; Thomas Michael O'Shea; Megan N Scott
Journal:  J Neuroimmune Pharmacol       Date:  2017-04-12       Impact factor: 4.147

3.  Describing the Increase in Preterm Births in the United States, 2014-2016.

Authors:  Joyce A Martin; Michelle J K Osterman
Journal:  NCHS Data Brief       Date:  2018-06

Review 4.  Cytokine assays: an assessment of the preparation and treatment of blood and tissue samples.

Authors:  Genoveva C E Keustermans; Sanne B E Hoeks; Jenny M Meerding; Berent J Prakken; Wilco de Jager
Journal:  Methods       Date:  2013-04-19       Impact factor: 3.608

5.  Circulating biomarkers in extremely preterm infants associated with ultrasound indicators of brain damage.

Authors:  Alan Leviton; Elizabeth N Allred; Raina N Fichorova; T Michael O'Shea; Lynn A Fordham; Karl K C Kuban; Olaf Dammann
Journal:  Eur J Paediatr Neurol       Date:  2018-01-31       Impact factor: 3.140

6.  Analysis of sensory processing in preterm infants.

Authors:  Thais Invenção Cabral; Louise Gracelli Pereira da Silva; Cláudia Maria Simões Martinez; Eloisa Tudella
Journal:  Early Hum Dev       Date:  2016-08-10       Impact factor: 2.079

7.  Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging.

Authors:  M J Bell; J L Ternberg; R D Feigin; J P Keating; R Marshall; L Barton; T Brotherton
Journal:  Ann Surg       Date:  1978-01       Impact factor: 12.969

8.  Global, regional, and national causes of under-5 mortality in 2000-15: an updated systematic analysis with implications for the Sustainable Development Goals.

Authors:  Li Liu; Shefali Oza; Dan Hogan; Yue Chu; Jamie Perin; Jun Zhu; Joy E Lawn; Simon Cousens; Colin Mathers; Robert E Black
Journal:  Lancet       Date:  2016-11-11       Impact factor: 79.321

9.  Cognitive trajectories from infancy to early adulthood following birth before 26 weeks of gestation: a prospective, population-based cohort study.

Authors:  Louise Linsell; Samantha Johnson; Dieter Wolke; Helen O'Reilly; Joan K Morris; Jennifer J Kurinczuk; Neil Marlow
Journal:  Arch Dis Child       Date:  2017-11-16       Impact factor: 3.791

Review 10.  Sex-Dependent Effects of Perinatal Inflammation on the Brain: Implication for Neuro-Psychiatric Disorders.

Authors:  Maryam Ardalan; Tetyana Chumak; Zinaida Vexler; Carina Mallard
Journal:  Int J Mol Sci       Date:  2019-05-08       Impact factor: 5.923

View more
  3 in total

1.  Postnatal Cytokine Trajectories in Very Preterm Infants.

Authors:  Marliese Dion Nist; Abigail B Shoben; Tondi M Harrison; Deborah K Steward; Rita H Pickler
Journal:  West J Nurs Res       Date:  2021-09-07       Impact factor: 1.967

Review 2.  Role of Vitamin E in Neonatal Neuroprotection: A Comprehensive Narrative Review.

Authors:  Sarah Kolnik; Thomas R Wood
Journal:  Life (Basel)       Date:  2022-07-20

3.  Neonatal sepsis is associated with behavioral abnormalities in very low birthweight infants at preschool age.

Authors:  Vito Giordano; Sophie Stummer; Claudia Lindtner; Renate Fuiko; Angelika Berger; Karin Pichler
Journal:  Front Pediatr       Date:  2022-07-18       Impact factor: 3.569

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.